Erlotinib

Erlotinib ATC Code L01XE03 : Antineoplastic and immunomodulating agents - Antineoplastic drugs - Other antineoplastic agents - Protein kinase inhibitors - Erlotinib
Erlotinib
Erlotinib
LatinErlotinibum
Routes..Oral
Pregnancy categoryD
FDA Approval Date2004-11-08
EMA Approval Date2005-09-19
Molecular Weight393.43572 g/mol
Molecular FormulaC22H23N3O4
CAS Number183321-74-6
Erlotinib 3D

Erlotinib list of brand/trade names

  • United Kingdom: Tarceva
  • Germany: Tarceva
  • Spain: Tarceva
  • Italy: Tarceva
  • Canada: Tarceva
  • Russia: Tarceva
  • Australia: Tarceva
  • Netherlands: Tarceva
  • Belgium: Tarceva
  • Denmark: Tarceva
  • Finland: Tarceva
  • Greece: Tarceva
  • India: Erleva
  • Ireland: Tarceva
  • Norway: Tarceva
  • Portugal: Tarceva
  • Sweden: Tarceva
  • Indonesia: Tarceva
  • Turkey: Ertinob and Tarceva


ATC Codes

  1. Alimentary tract and metabolisma
  2. Blood and blood forming organs
  3. Cardiovascular system
  4. Dermatological drugs
  5. Genitourinary system and reproductive hormones
  6. Systemic hormonal preparations, excluding reproductive hormones and insulins
  7. Antiinfectives for systemic use
  8. Antineoplastic and immunomodulating agents
  9. Musculoskeletal system
  10. Nervous system
  11. Antiparasitic products, insecticides and repellents
  12. Respiratory system
  13. Sensory organs
  14. Various ATC structures

The newly added categories

  1. Mecillinam
  2. Tofisopam
  3. Medazepam
  4. Chlordiazepoxide
  5. Diazepam
  6. Bacampicillin
  7. Pivmecillinam
  8. Tigecycline
  9. Amoxicillin
  10. Mezlocillin